ÂÜÀòÂÒÂ×

Professor of Cell biology and Oncology, Director at INSERM, Patrizia Paterlini-Bréchot is Rarecells’ Founder and President. In addition to fundamental research studies early in her career, she focused on applied research, targeting the domains of predictive oncology and prenatal diagnosis. In 2000, her research led to the discovery and development of the now patented ISET® technique for isolation and characterization of circulating tumor and fetal cells permitting predictive oncology and non invasive prenatal diagnosis. Prof Paterlini-Bréchot oversees the continuing development of the ISET® technology. Her work was acknowledged by numerous awards and led to high level scientific publications.